These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2861287)

  • 1. Synthesis of 4'-hydroxypropranolol sulfate, a major non-beta-blocking propranolol metabolite in man.
    Oatis JE; Walle T; Daniell HB; Gaffney TE; Knapp DR
    J Med Chem; 1985 Jun; 28(6):822-4. PubMed ID: 2861287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ring-hydroxylated propranolol: synthesis and beta-receptor antagonist and vasodilating activities of the seven isomers.
    Oatis JE; Russell MP; Knapp DR; Walle T
    J Med Chem; 1981 Mar; 24(3):309-14. PubMed ID: 6115057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.
    Fitzgerald JD; O'Donnell SR
    Br J Pharmacol; 1971 Sep; 43(1):222-35. PubMed ID: 4400184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A radioreceptor assay for propranolol and 4-hydroxypropranolol.
    Rochester CL; Gammon DE; Shane E; Bilezikian JP
    Clin Pharmacol Ther; 1980 Jul; 28(1):32-9. PubMed ID: 6248289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of major sulfate conjugates in the metabolism of propranolol in dog and man.
    Walle T; Walle UK; Knapp DR; Conradi EC; Bargar EM
    Drug Metab Dispos; 1983; 11(4):344-9. PubMed ID: 6137341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical aspects of propranolol metabolism. Synthesis and identification of 3-(4-hydroxy-1-naphthoxy)propane-1,2-diol as a metabolite of propranolol in the dog, in man and in the rat liver 9000g supernatant fraction.
    Gupte SM; Bartels MJ; Kerr BM; Laganiere S; Silber BM; Nelson WL
    Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):235-44. PubMed ID: 6658188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivatives of beta-adrenergic antagonists. N-Nitrosopropranolol and N-hydroxypropranolol and its aldonitrone.
    Zhang S; Powell ML; Nelson WL; Wirth PJ
    J Med Chem; 1983 Mar; 26(3):455-8. PubMed ID: 6131136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 3,4-catechol derivative of propranolol, a minor dihydroxylated metabolite.
    Nelson WL; Bartels MJ; Bednarski PJ; Zhang S; Messick K; Horng JS; Ruffolo RR
    J Med Chem; 1984 Jul; 27(7):857-61. PubMed ID: 6330358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and metabolism of the pharmacologically active 4'-hydroxylated metabolite of propranolol in the dog.
    Christ DD; Walle UK; Oatis JE; Walle T
    Drug Metab Dispos; 1990; 18(1):1-4. PubMed ID: 1970766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the rigidification of propranolol, a mixed
    Franchini S; Sorbi C; Linciano P; Brasili L; Tait A
    Pharmazie; 2019 Mar; 74(3):131-135. PubMed ID: 30961676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular actions of a new metabolite of propranolol: isopropylamine.
    Ishizaki T; Privitera PJ; Walle T; Gaffney TE
    J Pharmacol Exp Ther; 1974 Jun; 189(3):626-32. PubMed ID: 4152314
    [No Abstract]   [Full Text] [Related]  

  • 12. The pathways of propranolol metabolism in dog and rat liver 10,000g supernatant fractions.
    Vu VT; Abramson FP
    Drug Metab Dispos; 1980; 8(5):300-4. PubMed ID: 6107225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and chromatographic separation of the glucuronides of (R)- and (S)-propranolol.
    Oatis JE; Baker JP; McCarthy JR; Knapp DR
    J Med Chem; 1983 Dec; 26(12):1687-91. PubMed ID: 6644737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regioisomeric products of propranolol metabolism. The monomethyl ethers of 3,4-dihydroxypropranolol and of 3,4-dihydroxypropranolol glycol.
    Gustavson LM; Nelson WL
    Drug Metab Dispos; 1988; 16(2):217-21. PubMed ID: 2898336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of the new alpha- and beta-adrenergic antagonist 1-[1-(2-benzodioxanylmethyl)-4-piperidyl]amino-3-(1-naphthoxy)-2- propanol.
    Mauleón D; Antúnez S; Rosell G
    Farmaco; 1989 Nov; 44(11):1109-17. PubMed ID: 2577151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the haemodynamic effects of propranolol, 4-hydroxypropranolol and practolol in anaesthetized dogs.
    Fitzgerald JD; O'Donnell SR
    Br J Pharmacol; 1972 Jun; 45(2):207-17. PubMed ID: 4403100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and bioactivity of propranolol analogues with a rigid skeleton. I.
    Miki Y; Hachiken H; Noguchi K; Ohta M; Nakano A; Takahashi K; Takemura S
    Chem Pharm Bull (Tokyo); 1990 Dec; 38(12):3257-60. PubMed ID: 1982645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of propranolol and 4-hydroxypropranolol on platelet aggregation and thromboxane A2 generation.
    Mehta J; Mehta P; Ostrowski N
    Clin Pharmacol Ther; 1983 Nov; 34(5):559-64. PubMed ID: 6627818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and beta-adrenergic antagonist activity of stereoisomeric practolol and propranolol derivatives.
    Leftheris K; Goodman M
    J Med Chem; 1990 Jan; 33(1):216-23. PubMed ID: 1967313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.